Janine Guendel

Title: Janine Guendel: Innovator in Genetic Modification

Introduction

Janine Guendel is a prominent inventor based in Lachen, Switzerland. She has made significant contributions to the field of genetic engineering, particularly through her innovative work involving CRISPR technology. Her research focuses on modifying multiple alleles in genes, which has important implications for therapeutic applications.

Latest Patents

Janine Guendel holds a patent titled "Means and methods for modifying multiple alleles." This invention relates to a method of modifying at least one gene in a cell via CRISPR/Cas, wherein the gene has at least three alleles. The patent also covers cells that can be obtained through this method. Furthermore, it provides a method for producing proteins in cells modified by this technique, which can be utilized in various therapeutic contexts.

Career Highlights

Janine is currently associated with Octapharma AG, a company known for its focus on human proteins and innovative therapies. Her work at Octapharma AG has allowed her to apply her research in practical settings, contributing to advancements in medical treatments.

Collaborations

Janine collaborates with talented colleagues, including Karina Nawrath and Sven Bahrke, who share her commitment to advancing genetic research and its applications.

Conclusion

Janine Guendel's innovative work in genetic modification exemplifies the potential of CRISPR technology in therapeutic development. Her contributions continue to pave the way for future advancements in the field.